Skip to main content
Premium Trial:

Request an Annual Quote

Reaction Biology Wins $750K SBIR Grant to Apply Array Tech to Drug Discovery

NEW YORK, Aug. 9 (GenomeWeb News) - Reaction Biology has been awarded a $750,000 Phase II SBIR grant from the National Institutes of Health to apply its new DiscoveryDot microarray technology for drug discovery, the company said today.    


The grant, from the National Institute of Dental and Craniofacial Research, will fund the use of the technology for high throughput screening of caspases and other proteases, Reaction Biology said.


The company said its DiscoveryDot technology can screen up to 6,600 individual reactions. The one-nanoliter reaction volume used by the company "represents 1/10,000 the volume of conventional screening systems," Reaction Biology said.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.